Semaglutide, marketed as Ozempic and Wegovy, has taken the weight-loss world by storm.
Originally developed to treat Type 2 diabetes, its dramatic weight-loss effects quickly caught attention.
However, a study analyzing World Health Organization data raises serious concerns about its safety.
